Neuropsychological, neuropsychiatric and functional assessments help follow the course of Alzheimer's disease

March 3, 2015, University of Eastern Finland

The cognitive performance of persons with Alzheimer's disease and behavioural and psychological problems are linked to their performance of activities of daily living, according to a recent study completed at the University of Eastern Finland. However, difficulties in cognitive performance were not linked to behavioural and psychological problems, although both deteriorated as the disease progressed. Some persons may have significant problems in memory and other cognitive performance without the presence of behavioural and psychological problems, while others experience behavioural and psychological problems already at the early phase of the disease.

Diseases causing dementia are becoming increasingly common as the population ages and life expectancy increases. Alzheimer's disease (AD) is the most common cause of dementia, leading to progressing problems in memory and other cognitive performance. AD is also associated with deteriorated performance of activities of daily living, and increased need for assistance. Furthermore, AD is often associated with behavioural and . Information on the progression of the disease and its evaluation methods is needed for treatment planning and for the evaluation of treatment outcomes..

The PhD thesis of Ilona Hallikainen focuses on the progression of Alzheimer's symptoms after diagnosis, and sheds new light on the usability of the CERAD neuropsychological test battery in the monitoring of the progression of the disease. The study was a three-year follow-up of 236 persons with Alzheimer's disease and their caregivers from three Finnish hospital districts. The study constituted part of the multidisciplinary ALSOVA study coordinated by the Institute of Clinical Medicine (Neurology) at the University of Eastern Finland.

During the follow-up, difficulties in and activities of daily living as well as behavioural and psychological problems and the severity of the disease increased; however, approximately 50% of the study participants were diagnosed with a mild form of Alzheimer's disease after the three-year study period. An interesting observation was that persons who at the onset of the study were diagnosed with a very mild form of Alzheimer's disease and whose treatment had begun at the early phase experienced a slower decline in the performance of activities of and less frequent presence of behavioural problems. The study sheds new light on how the disease progresses in persons under current treatment.

The CERAD neuropsychological test battery is widely used in the early detection of Alzheimer's disease. The study discovered that the test battery's total score was a well-functioning measure in follow-up use. In clinical use, however, the use of the CERAD test battery for the monitoring of AD-related symptoms may be limited due to it requiring plenty of time. In the test battery, tasks assessing global cognition, language, visual perception and executive function were found to be very useful in follow-up use. Although memory problems are first signs of the disease, the role of other cognitive deficits increases as the disease progresses. The results open up new possibilities for the monitoring of the disease both in research and in clinical settings.

Explore further: Early detection and treatment of Alzheimer's disease prevents psychological and behavioral symptoms

Related Stories

Early detection and treatment of Alzheimer's disease prevents psychological and behavioral symptoms

July 18, 2013
Persons with Alzheimer's disease are able to manage their everyday activities longer and they suffer from less psychological and behavioural symptoms if the diagnosis is made and treatment begun at a very early phase of the ...

Study finds older adults with mild cognitive impairment may also have some functional impairment

June 6, 2011
Difficulty remembering important dates and medications, and gathering paperwork, is more common in older individuals with mild cognitive impairment than in those with no cognition problems, according to a report in the June ...

People with Alzheimer's disease more likely to suffer from heart disease—offered fewer treatment options than others

October 30, 2013
Persons with Alzheimer's disease suffer from ischaemic heart diseases more frequently than others, yet they undergo related procedures and surgery less frequently than persons with no diagnosed AD, according to a nation-wide ...

Quality of life and Alzheimer's assessed

August 19, 2014
A decline in cognitive functions does not necessarily mean lower health-related quality of life for people diagnosed with mild to moderate Alzheimer's disease, new research suggests.

Decline in daily functioning related to decreased brain activity in Alzheimer's

August 12, 2014
Decline in daily functioning associated with Alzheimer's disease is related to alterations in activity in certain regions of the brain, according to a study published in the August 2014 issue of the Journal of Alzheimer's ...

A new diagnostic tool for dementia diseases

June 5, 2014
A new diagnostic tool helps clinicians to differentiate between Alzheimer's disease, frontotemporal dementia and mild cognitive impairment. Presented in the doctoral thesis of MD Miguel Ángel Muñoz Ruiz at the University ...

Recommended for you

Energy storehouses in the brain may be source of Alzheimer's, targets of new therapy

January 23, 2018
Alzheimer's disease, a severely debilitating and ultimately fatal brain disorder, affects millions worldwide. To date, clinical efforts to find a cure or adequate treatment have met with dispiriting failure.

Rocky start for Alzheimer's drug research in 2018

January 19, 2018
The year 2018, barely underway, has already dealt a series of disheartening blows to the quest for an Alzheimer's cure.

Alzheimer's disease: Neuronal loss very limited

January 17, 2018
Frequently encountered in the elderly, Alzheimer's is considered a neurodegenerative disease, which means that it is accompanied by a significant, progressive loss of neurons and their nerve endings, or synapses. A joint ...

Anxiety: An early indicator of Alzheimer's disease?

January 12, 2018
A new study suggests an association between elevated amyloid beta levels and the worsening of anxiety symptoms. The findings support the hypothesis that neuropsychiatric symptoms could represent the early manifestation of ...

One of the most promising drugs for Alzheimer's disease fails in clinical trials

January 11, 2018
To the roughly 400 clinical trials that have tested some experimental treatment for Alzheimer's disease and come up short, we can now add three more.

Different disease types associated with distinct amyloid-beta prion strains found in Alzheimer's patients

January 9, 2018
An international team of researchers has found different disease type associations with distinct amyloid-beta prion strains in the brains of dead Alzheimer's patients. In their paper published in Proceedings of the National ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.